ESC Premium Access

P2Y12 inhibition should be started at the time of NSTEMI diagnosis - CON.

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Presentation

About the speaker

Professor Gilles Montalescot

Sorbonne University, Paris (France)
23 presentations
1 follower

5 more presentations in this session

P2Y12 inhibition should be started at the time of NSTEMI diagnosis - PRO.

Speaker: Professor M. Valgimigli (Lugano, CH)

Thumbnail

P2Y12 inhibition should be started at the time of NSTEMI diagnosis -Discussion

Thumbnail

Duration of DAPT should be beyond 1 year post acute coronary syndrome - PRO.

Speaker: Doctor M. Bonaca (Aurora, US)

Thumbnail

Duration of DAPT should be beyond 1 year post acute coronary syndrome - CON.

Speaker: Associate Professor G. De Luca (Novara, IT)

Thumbnail

Duration of DAPT should be beyond 1 year post acute coronary syndrome - Discussion

Thumbnail

Access the full session

Controversies in anti-platelet therapy

Speakers: Professor G. Montalescot, Professor M. Valgimigli, Doctor M. Bonaca, Associate Professor G. De Luca
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk